MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202441010882 A) filed by Teadus Pharma Private Limited on February 16, 2024, for A Process For The Preparation Of (2s,3s)-2-Benzhydryl-N-(5-Tert-Butyl-2- Methoxybenzyl) Quinuclidin-3-Amine (maropitant) And Its Pharmaceutically Acceptable Salts Thereof.
Inventors include Selvakumar Balaraman; Kasinathan Gopu; Sindhuja Rangisetty; Sai Anand Palanki; Archanadevi Kumaran; and Umamaheswar Siripurapu.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: ABSTRACT “A PROCESS FOR THE PREPARATION OF (2S,3S)-2-BENZHYDRYLN-(5-TERT-BUTYL-2- METHOXYBENZYL) QUINUCLIDIN-3-AMINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF” The present invention relates to a process for the preparation of (2S,3S)-2- benzhydryl-N-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine represented by the following structural formula-1a and its pharmaceutically acceptable salts 5 thereof. Further, the present invention provides 2S,3S)-2-benzhydryl-N-(5-tertbutyl-2-methoxybenzyl) quinuclidin-3-amine salts with purity greater than 99.0% by High- performance liquid chromatography (HPLC). It further relates to a process for the preparation of (S)-2-benzhydrylquinuclidin-3- 10 one (6) with purity greater than 99.0% by High-performance liquid chromatography (HPLC).
Disclaimer: Curated by HT Syndication.
